Ignite Creation Date:
2025-12-24 @ 11:25 PM
Ignite Modification Date:
2026-02-26 @ 11:15 AM
Study NCT ID:
NCT04247256
Status:
UNKNOWN
Last Update Posted:
2022-03-02
First Post:
2020-01-23
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase 2 Trial of SCO-101 in Combination With FOLFIRI for Patients With Metastatic Colorectal Cancer (mCRC) With Acquired Resistance to FOLFIRI
Sponsor:
Scandion Oncology A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-06-30
Completion Date Type:
ESTIMATED
First Submit Date:
2020-01-23
First Submit QC Date:
None
Study First Post Date:
2020-01-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-02-28
Last Update Post Date:
2022-03-02
Last Update Post Date Type:
ACTUAL